Citigroup Inc Bridge Bio Pharma, Inc. Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Citigroup Inc holds 1,790,070 shares of BBIO stock, worth $45.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,790,070

Previous 1,557,231 14.95%

Holding current value

$45.3 Million

Previous $62.9 Million 11.96%

% of portfolio

0.04%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $6.37 Million - $9.42 Million	232,839 Added 14.95%	1,790,070 $55.3 Million
Q4 2023 Feb 09, 2024	SELL	$24.02 - $43.89 $729,271 - $1.33 Million	-30,361 Reduced 1.91%	1,557,231 $62.9 Million
Q3 2023 Nov 09, 2023	BUY	$16.89 - $35.01 $2.7 Million - $5.6 Million	160,076 Added 11.21%	1,587,592 $41.9 Million
Q2 2023 Aug 10, 2023	SELL	$13.29 - $18.01 $1.59 Million - $2.15 Million	-119,529 Reduced 7.73%	1,427,516 $24.6 Million
Q1 2023 May 11, 2023	BUY	$7.17 - $18.55 $1.16 Million - $3.01 Million	162,116 Added 11.71%	1,547,045 $25.7 Million

Q4 2022 Feb 09, 2023	SELL	$6.74 - $11.52 $910,789 - $1.56 Million	-135,132 Reduced 8.89%	1,384,929 $10.6 Million
Q3 2022 Nov 10, 2022	BUY	$7.94 - $12.36 $362,532 - $564,345	45,659 Added 3.1%	1,520,061 $15.1 Million
Q2 2022 Aug 10, 2022	BUY	$5.21 - $12.14 $1.79 Million - $4.17 Million	343,362 Added 30.36%	1,474,402 $13.4 Million
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $596,727 - $1.4 Million	-81,298 Reduced 6.71%	1,131,040 $11.5 Million
Q4 2021 Feb 10, 2022	BUY	$11.38 - $53.41 $8.37 Million - $39.3 Million	735,295 Added 154.14%	1,212,338 $20.2 Million
Q3 2021 Nov 10, 2021	BUY	$46.87 - $64.24 $22.4 Million - $30.6 Million	477,043 New	477,043 $22.4 Million

Others Institutions Holding BBIO

# of Institutions

284

Shares Held

170M

Call Options Held

7.41M

Put Options Held

2.61M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.76B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account